Profarma Distribuidora de Produtos Farmacêuticos Balance Sheet Health
Financial Health criteria checks 5/6
Profarma Distribuidora de Produtos Farmacêuticos has a total shareholder equity of R$1.5B and total debt of R$779.9M, which brings its debt-to-equity ratio to 50.7%. Its total assets and total liabilities are R$4.9B and R$3.4B respectively. Profarma Distribuidora de Produtos Farmacêuticos's EBIT is R$261.1M making its interest coverage ratio 1.7. It has cash and short-term investments of R$193.7M.
Key information
50.7%
Debt to equity ratio
R$779.90m
Debt
| Interest coverage ratio | 1.7x |
| Cash | R$193.74m |
| Equity | R$1.54b |
| Total liabilities | R$3.40b |
| Total assets | R$4.94b |
Recent financial health updates
These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Feb 21
These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Jun 08These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Sep 26Here's Why Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Weighed Down By Its Debt Load
May 28Is Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Using Too Much Debt?
Jan 05Recent updates
Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) 28% Price Boost Is Out Of Tune With Earnings
Mar 01These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Feb 21Returns On Capital Are Showing Encouraging Signs At Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3)
Nov 04Investors Will Want Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Growth In ROCE To Persist
Aug 03These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Jun 08These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Sep 26Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3) Shares Fly 26% But Investors Aren't Buying For Growth
Jan 01Here's Why Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Weighed Down By Its Debt Load
May 28Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Might Have The Makings Of A Multi-Bagger
May 07How Much Of Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3) Do Institutions Own?
Mar 10Are Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 02
Is Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Using Too Much Debt?
Jan 05What Type Of Shareholders Make Up Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) Share Registry?
Dec 10Financial Position Analysis
Short Term Liabilities: PFRM3's short term assets (R$3.5B) exceed its short term liabilities (R$2.4B).
Long Term Liabilities: PFRM3's short term assets (R$3.5B) exceed its long term liabilities (R$952.3M).
Debt to Equity History and Analysis
Debt Level: PFRM3's net debt to equity ratio (38.1%) is considered satisfactory.
Reducing Debt: PFRM3's debt to equity ratio has reduced from 62.3% to 50.7% over the past 5 years.
Debt Coverage: PFRM3's debt is well covered by operating cash flow (33.5%).
Interest Coverage: PFRM3's interest payments on its debt are not well covered by EBIT (1.7x coverage).